Oncology & Cancer
Farydak approved for multiple myeloma
(HealthDay)—Farydak (panobinostat) has been approved by the U.S. Food and Drug Administration to treat multiple myeloma, a cancer of the blood.
Feb 24, 2015
0
2
News tagged with multiple myeloma
Oncology & Cancer
Case series addresses spine tumors in pregnancy
(HealthDay)—For most pregnant patients with benign spine tumors, surgery can be postponed until after delivery, according to a study published in the Feb. 1 issue of Spine.
Feb 9, 2015
0
7
Oncology & Cancer
Recommendations presented for MRI use in multiple myeloma
(HealthDay)—Recommendations for the use of magnetic resonance imaging (MRI) in multiple myeloma are presented in a consensus statement published online Jan. 20 in the Journal of Clinical Oncology.
Feb 3, 2015
0
15
Oncology & Cancer
How to attack and paralyze myeloma cells
Multiple myeloma is a malignant disease characterised by proliferation of clonal plasma cells in the bone marrow and typically accompanied by the secretion of monoclonal immunoglobulins that are detectable in the serum or ...
Jan 20, 2015
0
5
Medical research
Modified heat shock protein identified as plasma cell dyscrasis risk factor
Patients with plasma cell dyscrasis have high amounts of an abnormal immunoglobulin, called a paraprotein, in their blood. While many patients have no outward symptoms, paraproteins can impair immune function, thicken blood, ...
Dec 8, 2014
0
0
Oncology & Cancer
Narrow subset of cells is responsible for metastasis in multiple myeloma, study finds
Although it is among the most highly metastatic of all cancers, multiple myeloma is driven to spread by only a subset of the myeloma cells within a patient's body, researchers at Dana-Farber Cancer Institute have found in ...
Dec 8, 2014
0
0
Oncology & Cancer
Circulating RNA may provide prognostic tool for multiple myeloma
The "molecular mail" sent by multiple myeloma cells provides clues to how well patients with the disease are likely to respond to treatment, according to a study being presented at the annual meeting of the American Society ...
Dec 7, 2014
0
0
Oncology & Cancer
Unprecedented benefit seen in test of three-drug treatment for multiple myeloma
In the treatment of multiple myeloma, the addition of carfilzomib to a currently accepted two-drug combination produced significantly better results than using the two drugs alone, according to a worldwide research team led ...
Dec 6, 2014
0
0
Oncology & Cancer
Investigational oral drug combo shows promise for newly diagnosed multiple myeloma
The investigational drug ixazomib taken orally in combination with lenalidomide and dexamethasone shows promise in patients with newly diagnosed multiple myeloma, according to the results of a phase 1/2 study published in ...
Nov 17, 2014
0
0
Oncology & Cancer
Worse health-related quality of life for older cancer survivors
(HealthDay)—Health-related quality of life (HRQOL) is worse for older survivors of selected cancers, specifically survivors of multiple myeloma and pancreatic cancer, according to a study published online Nov. 4 in Cancer.
Nov 11, 2014
0
0
